Sculptor Capital’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Sculptor Capital’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,200	Closed	-$4.02K	–	468
2023 Q2	$4.02K	Sell	19,200 -100	-0.5%	-$18	﹤0.01%	422
2023 Q1	$2.8K	Sell	19,300 -700	-4%	-$100	﹤0.01%	521
2022 Q4	$1.75K	Hold	20,000	–	–	﹤0.01%	776
2022 Q3	$2K	Hold	20,000	–	–	﹤0.01%	1065
2022 Q2	$5K	Hold	20,000	–	–	﹤0.01%	1134
2022 Q1	$12K	Hold	20,000	–	–	﹤0.01%	1199
2021 Q4	$24K	Hold	20,000	–	–	﹤0.01%	1113
2021 Q3	$22K	Buy	+20,000	New	+$25K	﹤0.01%	948

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Sculptor Capital's NKGNW Position: Q3 2023 in Review

Sculptor Capital sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q3 2023, closing a stake of 19,200 shares — an estimated $4.02K sold.

Sculptor Capital first reported a position in NKGNW in Q3 2021 and held it in 8 quarters. The position peaked at $24K in Q4 2021. 21 funds tracked by Wall St. Rank hold NKGNW as of Q3 2023.

Sculptor Capital reported no remaining NKGen Biotech, Inc. Warrants position as of Q3 2023 after selling out during the quarter.
Sculptor Capital sold 19,200 NKGen Biotech, Inc. Warrants shares in Q3 2023, an estimated $4.02K.
Sculptor Capital first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 8 quarters.
Sculptor Capital's NKGen Biotech, Inc. Warrants position peaked at $24K in Q4 2021.
21 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q3 2023.

Based on Sculptor Capital's 13F filing for Q3 2023, filed 14 Nov 2023.